Stenobird

Episode

Mobile Health Smoking Cessation for Patients With TB, Nirsevimab vs Maternal RSVpreF Vaccine for RSV Prevention in Newborns, Self-Care and Spinal Manipulation for Low Back Pain, and more

Podcast
JAMA Editors' Summary
Published
Jan 2, 2026
Duration seconds
1033
Processing state
not_requested
Canonical source
https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2025.24749
Audio
https://traffic.libsyn.com/secure/jamaeditorsaudiosummary/Mobile_Health_Smoking_Cessation_for_Patients_With_TB_Nirsevimab_vs_Maternal_RSVpreF_Vaccine_for_RSV_Prevention_in_Newborns_Self-Care_and_Spinal_Manipulation_for_Low_Back_Pain_and_more.mp3?dest-id=90838
JSON
/v1/public/podcasts/jama-editors-summary-786043/episodes/mobile-health-smoking-cessation-for-patients-with-tb-nirsevimab-vs-maternal-rsvpref-vaccine-for-rsv-prevention-in-newborns-self-care-and-spinal-manipulation-for-low-back-pain-and-more
Markdown
/podcast/jama-editors-summary-786043/mobile-health-smoking-cessation-for-patients-with-tb-nirsevimab-vs-maternal-rsvpref-vaccine-for-rsv-prevention-in-newborns-self-care-and-spinal-manipulation-for-low-back-pain-and-more.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/jama-editors-summary-786043/episodes/mobile-health-smoking-cessation-for-patients-with-tb-nirsevimab-vs-maternal-rsvpref-vaccine-for-rsv-prevention-in-newborns-self-care-and-spinal-manipulation-for-low-back-pain-and-more/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/jama-editors-summary-786043/mobile-health-smoking-cessation-for-patients-with-tb-nirsevimab-vs-maternal-rsvpref-vaccine-for-rsv-prevention-in-newborns-self-care-and-spinal-manipulation-for-low-back-pain-and-more.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Editor's Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief, and Preeti Malani, MD, MSJ, Deputy Editor of JAMA, the Journal of the American Medical Association, for articles published from December 20,2025, through January 2, 2026 .